Potier, Marie-Claude
Centre National de la Recherche Scientifique · Inserm · Sorbonne Université · Pitié-Salpêtrière Hospital · Institut du Cerveau
19 papers on CoChatORCID 0000-0003-2462-7150
Most cited papers
- Verified
Cloning and sequencing of the cDNA encoding an isoform of microtubule‐associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain.
Goedert, M., Spillantini, M. G., Potier, M. C., Ulrich, J., & Crowther, R. A. (1989) · The EMBO Journal
Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms
Cited by 1,037
- Verified
Classification and basic pathology of Alzheimer disease
Duyckaerts, C., Delatour, B., & Potier, M.-C. (2009) · Acta Neuropathologica
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 1,031
- Verified
Early and protective microglial activation in Alzheimer’s disease: a prospective study using18F-DPA-714 PET imaging
Hamelin, L., Lagarde, J., Dorothée, G., Leroy, C., Labit, M., Comley, R. A., de Souza, L. C., Corne, H., Dauphinot, L., Bertoux, M., et al. (2016) · Brain
Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments
Cited by 519
- Verified
Classification of human chromosome 21 gene-expression variations in down syndrome: impact on disease phenotypes
Aït Yahya-Graison, E., Aubert, J., Dauphinot, L., Rivals, I., Prieur, M., Golfier, G., Rossier, J., Personnaz, L., Créau, N., Bléhaut, H., et al. (2007) · The American Journal of Human Genetics
Down syndrome and intellectual disability researchGenomic variations and chromosomal abnormalities
Cited by 338
- Verified
CYP46A1 inhibition, brain cholesterol accumulation and neurodegeneration pave the way for Alzheimer’s disease
Djelti, F., Braudeau, J., Hudry, E., Dhenain, M., Varin, J., Bièche, I., Marquer, C., Chali, F., Ayciriex, S., Auzeil, N., et al. (2015) · Brain
Alzheimer's disease research and treatmentsCholesterol and Lipid Metabolism
Cited by 223
- Verified
Distinct dynamic profiles of microglial activation are associated with progression of Alzheimer's disease
Hamelin, L., Lagarde, J., Dorothée, G., Potier, M. C., Corlier, F., Kuhnast, B., Caillé, F., Dubois, B., Fillon, L., Chupin, M., et al. (2018) · Brain
Neuroinflammation and Neurodegeneration MechanismsDementia and Cognitive Impairment Research
Cited by 177
- Verified
Parvalbumin deficiency affects network properties resulting in increased susceptibility to epileptic seizures
Schwaller, B., Tetko, I. V., Tandon, P., Silveira, D. C., Vreugdenhil, M., Henzi, T., Potier, M.-C., Celio, M. R., & Villa, A. E. P. (2004) · Molecular and Cellular Neuroscience
Epilepsy research and treatmentNeuroscience and Neuropharmacology Research
Cited by 169
- Verified
Clathrin adaptor CALM/PICALM is associated with neurofibrillary tangles and is cleaved in Alzheimer’s brains
Ando, K., Brion, J.-P., Stygelbout, V., Suain, V., Authelet, M., Dedecker, R., Chanut, A., Lacor, P., Lavaur, J., Sazdovitch, V., et al. (2013) · Acta Neuropathologica
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 136
- Verified
Patterns and severity of vascular amyloid in Alzheimer’s disease associated with duplications and missense mutations in APP gene, Down syndrome and sporadic Alzheimer’s disease
Mann, D. M. A., Davidson, Y. S., Robinson, A. C., Allen, N., Hashimoto, T., Richardson, A., Jones, M., Snowden, J. S., Pendleton, N., Potier, M.-C., et al. (2018) · Acta Neuropathologica
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 73
- Verified
DYRK1A inhibition and cognitive rescue in a Down syndrome mouse model are induced by new fluoro-DANDY derivatives
Neumann, F., Gourdain, S., Albac, C., Dekker, A. D., Bui, L. C., Dairou, J., Schmitz-Afonso, I., Hue, N., Rodrigues-Lima, F., Delabar, J. M., et al. (2018) · Scientific Reports
Down syndrome and intellectual disability researchAlzheimer's disease research and treatments
Cited by 71
- Verified
Glutamate receptors of the delta family are widely expressed in the adult brain
Hepp, R., Hay, Y. A., Aguado, C., Lujan, R., Dauphinot, L., Potier, M. C., Nomura, S., Poirel, O., El Mestikawy, S., Lambolez, B., et al. (2015) · Brain Structure and Function
Neuroscience and Neuropharmacology ResearchAmino Acid Enzymes and Metabolism
Cited by 71
- Verified
Differential default mode network trajectories in asymptomatic individuals at risk for Alzheimer’s disease
Chiesa, P. A., Cavedo, E., Vergallo, A., Lista, S., Potier, M., Habert, M., Dubois, B., Thiebaut de Schotten, M., Hampel, H., and the INSIGHT‐preAD study group, et al. (2019) · Alzheimer's & Dementia
Functional Brain Connectivity StudiesDementia and Cognitive Impairment Research
Cited by 66
- Verified
Ts66Yah, a mouse model of down syndrome with improved construct and face validity
Duchon, A., del Mar Muñiz Moreno, M., Chevalier, C., Nalesso, V., Andre, P., Fructuoso-Castellar, M., Mondino, M., Po, C., Noblet, V., Birling, M.-C., et al. (2022) · Disease Models & Mechanisms
Down syndrome and intellectual disability researchGenetics and Neurodevelopmental Disorders
Cited by 58
- Verified
Treating enhanced GABAergic inhibition in Down syndrome: Use of GABA α5-selective inverse agonists
Martínez-Cué, C., Delatour, B., & Potier, M.-C. (2014) · Neuroscience & Biobehavioral Reviews
Down syndrome and intellectual disability researchNeuroscience and Neuropharmacology Research
Cited by 58
- Verified
Multi-omics signature of brain amyloid deposition in asymptomatic individuals at-risk for Alzheimer's disease: The INSIGHT-preAD study
Xicota, L., Ichou, F., Lejeune, F.-X., Colsch, B., Tenenhaus, A., Leroy, I., Fontaine, G., Lhomme, M., Bertin, H., Habert, M.-O., et al. (2019) · EBioMedicine
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 51
- Verified
Role of cholesterol metabolism in the pathogenesis of Alzheimerʼs disease
Allinquant, B., Clamagirand, C., & Potier, M.-C. (2014) · Current Opinion in Clinical Nutrition and Metabolic Care
Alzheimer's disease research and treatmentsCholesterol and Lipid Metabolism
Cited by 47
- Verified
Reducing Gabaergic Inhibition Restores Cognitive Functions in a Mouse Model of Down Syndrome
Potier, M.-C., Braudeau, J., Dauphinot, L., & Delatour, B. (2014) · CNS & Neurological Disorders - Drug Targets
Down syndrome and intellectual disability researchNeuroscience and Neuropharmacology Research
Cited by 34
- Verified
Brain Aβ load association and sexual dimorphism of plasma BACE1 concentrations in cognitively normal individuals at risk for AD
Vergallo, A., Houot, M., Cavedo, E., Lemercier, P., Vanmechelen, E., De Vos, A., Habert, M., Potier, M., Dubois, B., Lista, S., et al. (2019) · Alzheimer's & Dementia
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 32
- Verified
Association of brain network dynamics with plasma biomarkers in subjective memory complainers
Chiesa, P. A., Houot, M., Vergallo, A., Cavedo, E., Lista, S., Potier, M. C., Zetterberg, H., Blennow, K., Vanmechelen, E., De Vos, A., et al. (2020) · Neurobiology of Aging
Functional Brain Connectivity StudiesDementia and Cognitive Impairment Research
Cited by 7
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free